All Stories

  1. The M.I.O.C. (Microbiota, Inflammation, Obesity, Cancer) Network
  2. The Impact of Microbiota on Musculoskeletal Injuries
  3. The Impact of Microbiota on Neurological Disorders: Mechanisms and Therapeutic Implications
  4. Relationship Between Human Microbiome and Helicobacter pylori
  5. Reply to: Further advancing emergency department triage prediction
  6. Feed the Eye to Heal the Eye
  7. Outcomes and Predictors of In-Hospital Mortality among Older Patients with Dementia
  8. Surgery for Locally Advanced Gastric Cancer in the Era of Neo-adjuvant Therapies: something new?
  9. Procalcitonin for the early discrimination of fever etiology in patients with systemic autoimmune diseases attending the emergency department
  10. Predicting in-hospital mortality in pulmonary embolism patients: development and external validation of PATHOS score
  11. Electric scooter–related accidents: a possible protective effect of helmet use on the head injury severity
  12. Frailty assessment as independent prognostic factor for patients ≥65 years undergoing urgent cholecystectomy for acute cholecystitis
  13. Gut Microbiota and Clostridium difficile: What We Know and the New Frontiers
  14. Adhesive small bowel obstruction in octogenarians: A 6-year retrospective single-center analysis of clinical management and outcomes
  15. Risk Factors Associated with Post-Operative Complications in Multidisciplinary Treatment of Descending Necrotizing Mediastinitis
  16. Multimodality Imaging Findings in Waterhouse-Friderichsen Syndrome: A Case Report and a Short Literature Review
  17. Long-Term Effects of Hospitalization for COVID-19 on Frailty and Quality of Life in Older Adults ≥80 Years
  18. Early Prognostic Stratification of Clostridioides difficile Infection in the Emergency Department: The Role of Age and Comorbidities
  19. ABCD2, ABCD2-I, and OTTAWA scores for stroke risk assessment: a direct retrospective comparison
  20. Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter?
  21. Use of POCUS in Chest Pain and Dyspnea in Emergency Department: What Role Could It Have?
  22. Reply to “In-Hospital Mortality Risk of Older Patients With COVID-19 Infection”
  23. Self-reported difficulty in walking 400 meters: the “red flag” for probable sarcopenia
  24. Gut Microbiota and Autoimmune Diseases: A Charming Real World Together with Probiotics
  25. Guillain–Barré syndrome from an emergency department view: how to better predict the outcome?
  26. Frailty Network in an Acute Care Setting: The New Perspective for Frail Older People
  27. Self-reported Difficulty in Walking 400 Meters: the “red Flag” for Probable Sarcopenia
  28. One Year of COVID-19: Lessons Learned in a Hand Trauma Center
  29. Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study
  30. Frailty Assessment in the Emergency Department for Patients ≥80 Years Undergoing Urgent Major Surgical Procedures
  31. Frailty in Elderly Patients with Covid-19: A Narrative Review
  32. PECARN Rule in diagnostic process of pediatric patients with minor head trauma in emergency department
  33. The effects of COVID‐19 outbreak on pediatric emergency department admissions for acute wheezing
  34. Determinants of antibiotic prescriptions in a large cohort of children discharged from a pediatric emergency department
  35. Clinical Characteristics and Predictors of In-Hospital Mortality among Older Patients with Acute Heart Failure
  36. Gastric emergencies in older adults: not always the same old story! A tertiary care emergency department observational cohort study
  37. Hip Fracture Risk in Elderly With Non-End-Stage Chronic Kidney Disease: A Fall Related Analysis
  38. Factors Associated with ICU Admission in Patients with COVID-19: The GOL2DS Score
  39. Management of acute cholecystitis in elderly patients: A propensity score-matched analysis of surgical vs. medical treatment
  40. Are oral anticoagulants a risk factor for mild traumatic brain injury progression? A single-center experience focused on of direct oral anticoagulants and vitamin K antagonists
  41. Prognostic Factors for Surgical Failure in Malignant Bowel Obstruction and Peritoneal Carcinomatosis
  42. The Use of Chitotriosidase as a Marker of Active Sarcoidosis and in the Diagnosis of Fever of Unknown Origin (FUO)
  43. Predictors of clinical severity in subjects attending the Emergency Department for substance use: a ten-year cross-sectional study
  44. A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19
  45. Incidence and Predictors of Thrombotic Complications in 4742 Patients with COVID-19 or Other Acute Infectious Respiratory Diseases: A Propensity Score-Matched Study
  46. Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization
  47. IBI Score to Improve Clinical Practice in Newborns and Infants ≤ 60 Days with Fever in the Emergency Department
  48. Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study
  49. Early Procalcitonin Assessment in the Emergency Department in Patients with Intra-Abdominal Infection: An Excess or a Need?
  50. Microbiota and Myopericarditis: The New Frontier in the Car-Diological Field to Prevent or Treat Inflammatory Cardiomyo-Pathies in COVID-19 Outbreak
  51. Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey
  52. Proadrenomedullin in Sepsis and Septic Shock: A Role in the Emergency Department
  53. Frailty Assessment in the Emergency Department for Risk Stratification of COVID-19 Patients Aged ≥80 Years
  54. Microbiota and Probiotics: The Role of Limosilactobacillus Reuteri in Diverticulitis
  55. Presepsin as Early Marker of Sepsis in Emergency Department: A Narrative Review
  56. Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients?
  57. Role of serum procalcitonin in predicting the surgical outcomes of acute calculous cholecystitis
  58. Predictors of in-hospital mortality AND death RISK STRATIFICATION among COVID-19 PATIENTS aged ≥ 80 YEARs OLD
  59. Prognostic Role of Serum Procalcitonin Measurement in Adult Patients Admitted to the Emergency Department with Fever
  60. Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases
  61. Adhesive small bowel obstruction in elderly patients: a single-center analysis of treatment strategies and clinical outcomes
  62. Impact of COVID‐19 outbreak in acute bronchiolitis: Lesson from a tertiary Italian Emergency Department
  63. Energy drinks: a narrative review of their physiological and pathological effects
  64. Gut Microbiota and Environment in Coronary Artery Disease
  65. Gut Microbiota and Acute Diverticulitis: Role of Probiotics in Management of This Delicate Pathophysiological Balance
  66. Effect of influenza vaccine on COVID-19 mortality: a retrospective study
  67. PECARN rule in diagnostic process of pediatric patients with minor head trauma in emergency department
  68. The Role of Early Procalcitonin Determination in the Emergency Departiment in Adults Hospitalized with Fever
  69. Development and Validation of Predictive Assessment of Complicated Diverticulitis Score
  70. Reply to: Comment on Predicting In‐Hospital Mortality in COVID‐19 Older Patients with Specifically Developed Scores
  71. Utility of a pediatric observation unit for the management of children admitted to the emergency department
  72. Prognostic role of hypothyroidism and low free-triiodothyronine levels in patients hospitalized with acute heart failure
  73. Blood Glucose Levels Combined with Triage Revised Trauma Score Improve the Outcome Prediction in Adults and in Elderly Patients with Trauma
  74. Angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID‐19
  75. Predicting In‐Hospital Mortality in COVID ‐19 Older Patients with Specifically Developed Scores
  76. Electrocardiographic Findings and Clinical Outcome in Patients with COVID-19 or Other Acute Infectious Respiratory Diseases
  77. COVID-19 and intestinal inflammation: Role of fecal calprotectin
  78. Predicting intensive care unit admission and death for COVID-19 patients in the emergency department using early warning scores
  79. Electrocardiographic findings at presentation and clinical outcome in patients with SARS-CoV-2 infection
  80. Rapid Clinical Management of Leishmaniasis in Emergency Department: A Case Report with Clinical Review of Recent Literature
  81. Authors' reply to: Comment to better understanding of the study “Clinical characteristics and prognostic factors in COVID ‐19 patients aged ≥80 years”
  82. Non-COVID Diseases during the Pandemic: Where Have All Other Emergencies Gone?
  83. Early procalcitonin determination in the emergency department and clinical outcome of community-acquired pneumonia in old and oldest old patients
  84. Assessment of neurological manifestations in hospitalized patients with COVID‐19
  85. Euthyroid sick syndrome in hip fractures: Evaluation of postoperative anemia
  86. Role of Troponin Determination to Diagnose Chest Pain in the Pediatric Emergency Department
  87. Clinical characteristics and prognostic factors in COVID‐19 patients aged ≥80 years
  88. Acute Diverticulitis in Elderly Patients: Does Age Really Matter?
  89. Fecal calprotectin and need of multiple microbiota trasplantation infusions in Clostridium difficile infection
  90. Acute pancreatitis in oldest old
  91. SPONTANEOUS THYROID NODULE HEMORRHAGE IN THE EMERGENCY DEPARTMENT
  92. Risk factors for bloodstream infections in gynecological cancer
  93. Euthyroid sick syndrome in hip fractures: Valuation of vitamin D and parathyroid hormone axis
  94. Use of the PEPTEST™ tool for the diagnosis of GERD in the Emergency Department
  95. EP704 Is SOFA score reliable in a gynecologic oncology setting or is something missing? A retrospective study on predictors and risk factors for bloodstream infections
  96. Reduced utility of early procalcitonin and blood culture determination in patients with febrile urinary tract infections in the emergency department
  97. Review: Helicobacter pylori and extragastric diseases
  98. A new clinical score for cranial CT in ED non-trauma patients: Definition and first validation
  99. Supplementation with Lactobacillus reuteri ATCC PTA 4659 in patients affected by acute uncomplicated diverticulitis: a randomized double-blind placebo controlled trial
  100. Characteristics and in-hospital outcome of patients with no ST-segment elevation acute coronary syndrome and no obstructive coronary artery disease in the era of high-sensitivity troponins
  101. Could hypoglycemia and hypoalbuminemia allow the identification of septic patients at high mortality risk in addition of clinical scores?
  102. Acute pancreatitis in elderly patients: a single-center retrospective evaluation of clinical outcomes
  103. The author responds: The need for prospective studies of cranial CT for ED head trauma patients
  104. P.01.29 MANAGEMENT OF CAUSTIC INGESTIONS IN A TERTIARY EMERGENCY DEPARTMENT: A 3-YEAR CROSS-SECTIONAL STUDY
  105. P.02.20 SUPPLEMENTATION WITH LACTOBACILLUS REUTERI ATCC PTA 4659 IN PATIENTS AFFECTED BY ACUTE UNCOMPLICATED DIVERTICULITIS: A RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED TRIAL
  106. Dorsolateral Prefrontal Cortex Impairment in Methoxetamine-Induced Psychosis: An 18F-FDG PET/CT Case Study
  107. A 12-year retrospective analysis of differences between elderly and oldest old patients referred to the emergency department of a large tertiary hospital
  108. The Use of Probiotics in Different Phases of Diverticular Disease
  109. Fecal calprotectin in management of Clostridium difficile infection: a longitudinal study
  110. Acute intoxication and poisoning in children: the experience of a tertiary-care hospital from 2001-2012
  111. Ingestion of foreign bodies in children: the experience of a third-level single center from 2001 to 2012
  112. Emergencies in cancer patients: data on 15,623 cases from a large volume single centre from 2001 to 2013
  113. 1629 Emergencies in cancer patients: Data on 15,623 cases from a large volume single centre
  114. Emergency care in cancer patients: Data on 15,623 cases from a large volume single centre.
  115. Biomarkers in the prediction and management of acute coronary syndromes: current perspectives
  116. Looking for Celiac Disease in Italian Women with Endometriosis: A Case Control Study
  117. Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial
  118. Fibroblast growth factor 23 (FGF23) gene polymorphism in children with Kawasaki syndrome (KS) and susceptibility to cardiac abnormalities
  119. Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents
  120. Improved Outcomes for Rectal Cancer in the Era of Preoperative Chemoradiation and Tailored Mesorectal Excision: A Series of 338 Consecutive Cases
  121. P.1.76: PREVALENCE AND NATURAL HISTORY OF HEPATITIS B AND C VIRUS INFECTION IN A LARGE COHORT OF PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE IN TREATMENT WITH ANTI-TNF-A AGENTS
  122. Do Perioperative Blood Transfusions Influence Prognosis of Gastric Cancer Patients? Analysis of 927 Patients and Interactions with Splenectomy
  123. Fecal calprotectin concentrations in alcoholic patients
  124. Clinical trial: the effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy - a randomized, double-blind, cross-over, placebo-controlled study
  125. Can chronic gastritis cause an increase in fecal calprotectin concentrations?
  126. Low-dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms
  127. Four Hundred Consecutive Total Gastrectomies for Gastric Cancer
  128. Retroperitoneal Soft Tissue Sarcoma: Prognostic Factors and Therapeutic Approaches
  129. Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver
  130. OC3.09.2 EFFECT OF LACTOSE AMOUNT PRESENT IN DRUGS ON H2 EXCRETION AND GASTROINTESTINAL SYMPTOMS
  131. Giant Retroperitoneal Sarcomas: A Single Institution Experience
  132. Fecal Calprotectin in First-Degree Relatives of Patients with Ulcerative Colitis
  133. Prophylactic aspirin therapy does not increase faecal calprotectin concentrations
  134. Ischaemic jejunal vasculitis during treatment with pegylated interferon-alpha 2b and ribavirin for hepatitis C virus related cirrhosis
  135. Comparison between intravenous iron gluconate alone and intravenous iron gluconate plus levofolinic acid for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease
  136. Long-Term Results After Neoadjuvant Radiochemotherapy for Locally Advanced Resectable Extraperitoneal Rectal Cancer
  137. Increased carotid intima-media thickness in patients with inflammatory bowel disease
  138. Impact of Emergency Surgery in the Outcome of Rectal and Left Colon Carcinoma
  139. Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma
  140. Pancreatoduodenectomy for Tumors of Vater’s Ampulla: Report on 94 Consecutive Patients
  141. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre
  142. Effect of exogenous β-galactosidase in patients with lactose malabsorption and intolerance: a crossover double-blind placebo-controlled study
  143. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence
  144. Nasojejunal Tube Placement After Total Gastrectomy
  145. EPIDEMIOLOGY OF PATIENTS ADMITTED TO EMERGENCY DEPARTMENT WITH HYPERTENSION
  146. Hepatocellular carcinomas <2 cm in diameter complicating cirrhosis: ultrasound and clinical features in 153 consecutive patients
  147. Preoperative Radiotherapy Combined With Intraoperative Radiotherapy Improve Results of Total Mesorectal Excision in Patients With T3 Rectal Cancer
  148. Contrast‐enhanced power Doppler of the intestinal wall in the evaluation of patients with Crohn disease
  149. Probiotic Treatment Increases Salivary Counts of Lactobacilli: A Double-Blind, Randomized, Controlled Study
  150. Prognosis of patients with hepatocellular carcinoma (HCC) according to okuda staging system, clip staging system and BCLC staging classification: results of a single italian centre
  151. Evaluation of the albumin-gamma-glutamyltransferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis
  152. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study
  153. Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas
  154. Doppler ultrasonographic evaluation of the early changes in renal resistive index in cirrhotic patients undergoing liver transplantation.
  155. Early renal involvement in diabetes mellitus: comparison of renal Doppler US and radioisotope evaluation of glomerular hyperfiltration.
  156. Family history of peptic ulcer and a positive 13C urea breath test are predictive of gastroduodenal ulcer disease in uninvestigated dyspeptic patients
  157. Hereditary Nonpolyposis Colorectal Cancer: An Approach to the Selection of Candidates to Genetic TestingBased on Clinical and MolecularCharacteristics
  158. Characterization ofMSH2 andMLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer
  159. NUP 2506 Early renal involvement in insulin dependent diabetes mellitus (IDDM): Comparison between renal duplex doppler and radioisotopic evaluation of glomerular hyperfiltration
  160. IMP 1204 Renal resistivity index (RI) in cirrhotic patients undergoing orthotopic liver transplantation
  161. Magnetocardiographically-Guided Catheter Ablation